Medtech firm plans clinical trials following €6.7 million investment | Business Post

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 71%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Medtech Versono’s Fastwire intravascular device is designed to allow doctors get through the most difficult blockages they find in arteries, emmetjryan reports.

Finbar Dolan, chief executive, Versono: ‘The investment means we’ll be able to get the product out in front of a large community of doctors and start that process of commercialisation’

Versono, a medical devices company based in Galway, plans to have the first two clinical trials of its intravascular device completed by the end of next year.“The investment allows us to go ahead with our clinical trials. It means we’ll be able to get the product out in front of a large community of doctors and start that...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in NG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Chinese investor claims cash-for-visa firm no longer operating in Ireland | Business PostZhiming Xi, who invested €1m through the Immigrant Investor Programme, is suing the Huawen Foundation after it failed to respond to his concerns
Source: businessposthq - 🏆 8. / 71 Read more »

Stripe’s valuation upgraded as firm looks to learn from Plaid ‘kerfuffle’ | Business PostFidelity Investments has marked up the value of its stake in Stripe, the online payments company, having downgraded it earlier this year.
Source: businessposthq - 🏆 8. / 71 Read more »

Dept of Health reviewing HSE’s business case for relocation of NMH | Business PostThe HSE’s business case for the controversial relocation of the National Maternity Hospital is undergoing a technical review by the Department of Health as part of new rules to stop a repeat of the National Children’s Hospital budget’s overrun.
Source: businessposthq - 🏆 8. / 71 Read more »